Menu
GeneBe

7-96121309-A-G

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_014251.3(SLC25A13):c.1910T>C(p.Val637Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00026 in 1,614,082 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V637I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00066 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 0 hom. )

Consequence

SLC25A13
NM_014251.3 missense

Scores

1
10
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2

Conservation

PhyloP100: 9.16
Variant links:
Genes affected
SLC25A13 (HGNC:10983): (solute carrier family 25 member 13) This gene is a member of the mitochondrial carrier family. The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in this gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.031053305).
BP6
Variant 7-96121309-A-G is Benign according to our data. Variant chr7-96121309-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 203938.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=5, Likely_benign=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC25A13NM_014251.3 linkuse as main transcriptc.1910T>C p.Val637Ala missense_variant 18/18 ENST00000265631.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC25A13ENST00000265631.10 linkuse as main transcriptc.1910T>C p.Val637Ala missense_variant 18/181 NM_014251.3 A1Q9UJS0-1
SLC25A13ENST00000416240.6 linkuse as main transcriptc.1913T>C p.Val638Ala missense_variant 18/181 P5Q9UJS0-2
SLC25A13ENST00000494085.1 linkuse as main transcriptn.413T>C non_coding_transcript_exon_variant 2/22

Frequencies

GnomAD3 genomes
AF:
0.000664
AC:
101
AN:
152092
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00198
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000259
AC:
65
AN:
251420
Hom.:
0
AF XY:
0.000206
AC XY:
28
AN XY:
135876
show subpopulations
Gnomad AFR exome
AF:
0.00234
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000149
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000218
AC:
318
AN:
1461872
Hom.:
0
Cov.:
31
AF XY:
0.000215
AC XY:
156
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.00227
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.000727
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000180
Gnomad4 OTH exome
AF:
0.000315
GnomAD4 genome
AF:
0.000664
AC:
101
AN:
152210
Hom.:
1
Cov.:
32
AF XY:
0.000699
AC XY:
52
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.00198
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000404
Hom.:
0
Bravo
AF:
0.000812
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMar 01, 2021In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 27, 2018- -
Citrullinemia type II Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Late-onset citrullinemia Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Nov 11, 2019- -
Citrullinemia type I Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Neonatal intrahepatic cholestasis due to citrin deficiency;C1863844:Citrullinemia type II Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Citrin deficiency Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 25, 2024- -
SLC25A13-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJan 09, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.080
Cadd
Uncertain
23
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.73
D;.
Eigen
Benign
0.067
Eigen_PC
Benign
0.15
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.031
T;T
MetaSVM
Uncertain
-0.20
T
MutationAssessor
Benign
1.8
L;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-3.8
D;D
REVEL
Uncertain
0.59
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
0.13
B;.
Vest4
0.38
MVP
0.82
MPC
0.16
ClinPred
0.15
T
GERP RS
4.6
Varity_R
0.65
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148962110; hg19: chr7-95750621; API